RxDoctor Payments Data

Leah Fountain, NP

Family · Mountain Home, ARNPI 1487176764

Payments from drug & device makers

$2,977in general payments, 2019–2025

Across 172 payments — averaging $17.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$548
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$395
  • Novartis$337
  • Pfizer$248
  • Merck$243
  • AstraZeneca$168
  • plus $1K from 17 others

What the payments were for

  • Food & beverage$2,85696%
  • Education$1204%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,977 in reported general payments places this provider in the 85th percentile of 2,103 family providers in Arkansas.

See all family providers in Arkansas

Medicare billing

Part B allowed, 2024
$134,688
Medicare patients
1,002
Services billed
3,696

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban272$248,702
EntrestoSacubitril/Valsartan137$124,175
XareltoRivaroxaban135$105,636
Repatha SureclickEvolocumab44$26,910
BrilintaTicagrelor30$25,227
FarxigaDapagliflozin Propanediol26$18,558
Repatha SyringeEvolocumab14$16,324
MultaqDronedarone Hcl11$11,195
Metoprolol Succinate470$5,580
ClopidogrelClopidogrel Bisulfate448$4,288
Atorvastatin Calcium344$2,291
Carvedilol342$1,780
Losartan Potassium214$1,713
Isosorbide Dinitrate61$1,670
Isosorbide Mononitrate ErIsosorbide Mononitrate191$1,669

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$248$248,702272 claims
NovartisEntresto$337$124,175137 claims
Johnson & JohnsonXarelto$125$105,636135 claims
AstraZenecaBrilinta, Farxiga$168$43,78556 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,103 family providers in Arkansas.

Other family in Mountain Home

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →